Detection of CD5 antigen on B cell lymphomas in fixed, paraffin embedded tissues using signal amplification by catalyzed reporter deposition

European Journal of Histochemistry

Volumn 42, Issue 1, 1998, Pages 31-39

  Luo, J H ^a   Matsushima, A Y ^a   Chen, R ^a   Szabolcs, M J ^a  

^a College of Physicians and Surgeons ^*  (United States)

Author keywords

Amplification; CD5; Lymphoma; Signal; Tyramide

Indexed keywords

BIOTIN; BIOTINYLTYRAMIDE; CD5 ANTIGEN; DRUG DERIVATIVE; PARAFFIN; TYRAMINE;

ARTICLE; B CELL LYMPHOMA; CATALYSIS; HUMAN; IMMUNOLOGY; METHODOLOGY; PATHOLOGY; STAINING; TISSUE FIXATION;

ANTIGENS, CD5; BIOTIN; CATALYSIS; HUMANS; LYMPHOMA, B-CELL; PARAFFIN EMBEDDING; STAINING AND LABELING; TISSUE FIXATION; TYRAMINE;

EID: 0031970380     PISSN: 1121760X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Ballesteros E., Osborne B.M , and Matsushima A.Y. CD5+ Low grade marginal zone B cell lymphomas with localized presentation. Am. J. Surg. Pathol. in press.
2. Ben-Ezra J.M., and Kornstein M.J. Antibody NCL-CD5 fails to detect neoplastic CD5+ cells in paraffin sections. Am. J. Clin. Path. 106, 370-373, 1996.
3. Bobrow M.N., Harris T.D., Shaughnessy K.J., and Litt G.J. Catalyzed reporter deposition, a novel method of signal amplification. Application to immunoassays. J. Immunol. Methods 125, 279-285, 1989.
4. Butmarc J., Kourea H.P., and Kadin M.E. CDS immunostaining of lymphoid neoplasms in paraffin sections (letter). Am. J. Clin. Pathol. 107, 496, 1997.
5. Caligaris-Cappio F., Gobbi M., Bofill M., and Janossy G. Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia. J. Exp. Med. 155, 623-628, 1982.
6. Caligaris-Cappio F., and Janossy G. Surface marker in chronic lymphoid leukemias of B cell type. Sermin. Hematol. 22, 1-12, 1985.
7. Cantor H., and Boyse E.A. Functional subclasses of T lymphocytes bearing Ly antigens. I. The generation of functionally distinct T-cell subclasses is a differentiative process independent of antigen. J. Exp. Med. 141, 1376-1389, 1975.
8. Dorfman D.M., and Shahsafaei A. Usefulness of a new CD5 antibody for the diagnosis of T-cell and B cell lymphoproliferative disorders in paraffin sectons. Modern Path. 10, 859-863, 1997.
9. Harris N.L., Jaffe E.S., Stein H., et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84, 1361-92, 1994.
10. Hoffmann S., Rist B., Videnov G., Jung G., and Beck-Sickinger A.G. Structure-affinity studies of C-terminally modified analogs of neuropeptide Y led to a novel class of peptidic Y1 receptor antagonist. Regulatory Peptides 65, 61-70, 1996.
11. Hunyady B., Hipkin R.W., Schonbrunn A., and Mezey E. Immunohistochemical localization of somatostatin receptor SST2A in the rat pancreas. Endocrinology 138, 2632-2635, 1997.
12. Hunyady B , Krempels K., Harta G., and Mezey E. Immunohistochemical signal amplification by catalyzed reporter deposition and its application in double immunostaining. J. Histochem. Cytochem 44, 1353-1362, 1996.
13. Kipps TJ, Fong S, Tomhave E, Chen P.P, Goldfien R.D, and Carson D. A. High frequency expression of a conserved kappa light-chain variable-region gene in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci USA 84, 2916-2920, 1987.
14. Kipps T J. The CD5 cells. Advances in Immunology 47, 117-187, 1989.
15. Lanier L.L., Warner N.L., Ledbetter J.A., and Herzenber L.A. Expression of Lyt-1 antigen on certain murine B cell lymphomas. J. Exp. Med 153, 998-1003, 1980.
16. Ledbetter J.A, Rouse R.V, Micklem H.S., and Herzenberg L.A. T cell subsets defined by expression of Lyt-1,2,3 and Thy-I antigens. Two parameter immunofluorescence and cytotoxicity analysis with monoclonal antibodies modifies current views. J. Exp. Med. 152, 280-295, 1980.
17. Merz H., Malisius R., Mannweiler S., Zhou R., Hartmann W., Orscheschek K., Moubayed P., and Feller A.C. MmmunoMax, a maximized immunohistochemical method for the retrieval and enhancement of hidden antigens. Lab. Invest. 73, 149-156, 1995.
18. Plenat F., Picard E., Antunes L., Vignaud J., Marie B., Chalabreysse O., and Muhale F. Amplification of immunologic reactions using catalytic deposition at the reaction sites of tyrarnine derivatives. A decisive gain in sensitivity in immunohistochemistry and in situ hybridization. Annales de Pathologie 17, 17-23, 1997.
19. Salhany K.E., Van de Rijn M., Montone KT., and Tomaszewski J.E. CD5 immunostaining of lymphoid neoplasms in paraffin sections (letter). Am. J. Clin. Pathol. 107, 496, 1997.
20. Schmidt B.F., Chao J , Zhu A., DeBiasio R.L., and Fisher G. Signal amplification in the detection of single-copy DNA and RNA by enzyme-catalyzed deposition (CARD) of the novel fluorescent reporter substrate Cy3.29-tyramide. J. Histochem. Cytochem. 45, 365-373, 1997.
21. Wang C.Y., Good R., Ammirati P., Dymbort G., and Evans R.L. Identification of a p69.71 complex expressed on human T cells sharing determinants with B-type chronic lymphatic leukemic cells. J. Exp. Med. 151. 1539-1544, 1980.
22. Zehbe I., Hacker G.W., Su H., Hause-Kronberger C., Hainfeld J.F., and Tubbs R. Sensitive in situ hubridization with catalyzed reporter deposition, streptavidin-Nanogold, and silver acetate autometallography:detection of single-copy human papillomavirus. Am. J. Pathol. 150, 1553-1556, 1997.